TickerFacts.

Anteris Technologies Global Corp. (AVR): R&D Expense

Annual figures by period end, from SEC filings.

$69.12M
Year ended 2025-12-31
$77.15M
Trailing 12 months to 2026-06-30
2024-12-31: $51.45M2025-12-31: $69.12M$69.12M
2024-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$69.12M+34.3%2026-02-26, From 2025-01-01
2024-12-31$51.45Mn/a2026-02-26, From 2024-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Anteris Technologies Global Corp. (AVR)2025-12-31$69.12M+34.3%
NutriBand Inc. (NTRB)2026-01-31$1.89M-39.4%
CollPlant Biotechnologies Ltd (CLGN)2025-12-31$8.19M-22.1%
ENvue Medical, Inc. (FEED)2025-12-31$1.76M+93.8%
Safe Pro Group Inc. (SPAI)2025-12-31$394.2K+336.2%
Milestone Scientific Inc. (MLSS)2025-12-31$449.5K-47.7%
LogicMark, Inc. (LGMK)2025-12-31$617.4K+10.5%
Envoy Medical, Inc. (COCH)2025-12-31$12.49M+22.7%
Jin Medical International Ltd. (ZJYL)2025-09-30$1.56M+4.0%

Compare AVR, NTRB, CLGN, FEED side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗